A Study of Multiple Doses of ALXN1210 in Healthy Adult Participants - NCT05288673

Participants With Treatment-Emergent Adverse Events, Area Under The Concentration-time Curve From Time 0 (Dosing) To Infinity (AUCinf) Of Serum ALXN1210, AUC From Time Zero To The Time Of The Last Quantifiable Concentration (AUCt) Of Serum ALXN1210, (and 6 more...)